These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

681 related articles for article (PubMed ID: 27089521)

  • 1. Lurasidone adjunctive with lithium or valproate for bipolar depression: A placebo-controlled trial utilizing prospective and retrospective enrolment cohorts.
    Suppes T; Kroger H; Pikalov A; Loebel A
    J Psychiatr Res; 2016 Jul; 78():86-93. PubMed ID: 27089521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lurasidone as adjunctive therapy with lithium or valproate for the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study.
    Loebel A; Cucchiaro J; Silva R; Kroger H; Sarma K; Xu J; Calabrese JR
    Am J Psychiatry; 2014 Feb; 171(2):169-77. PubMed ID: 24170221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Safety of Adding Lurasidone to Ongoing Therapy With Lithium or Valproate for the Treatment of an Acute Bipolar Depressive Episode: A Post Hoc Analysis of 2 Placebo-Controlled Trials.
    Tocco M; Mao Y
    J Clin Psychopharmacol; 2024 Jul-Aug 01; 44(4):345-352. PubMed ID: 38639433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lurasidone in combination with lithium or valproate for the maintenance treatment of bipolar I disorder.
    Calabrese JR; Pikalov A; Streicher C; Cucchiaro J; Mao Y; Loebel A
    Eur Neuropsychopharmacol; 2017 Sep; 27(9):865-876. PubMed ID: 28689688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lurasidone: a review of its use in adult patients with bipolar I depression.
    Sanford M; Dhillon S
    CNS Drugs; 2015 Mar; 29(3):253-63. PubMed ID: 25698146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects on health-related quality of life in patients treated with lurasidone for bipolar depression: results from two placebo controlled bipolar depression trials.
    Rajagopalan K; Bacci ED; Ng-Mak D; Wyrwich K; Pikalov A; Loebel A
    BMC Psychiatry; 2016 May; 16():157. PubMed ID: 27215976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study.
    Vieta E; Owen R; Baudelet C; McQuade RD; Sanchez R; Marcus RN
    Curr Med Res Opin; 2010 Jun; 26(6):1485-96. PubMed ID: 20429835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lurasidone Dose Response in Bipolar Depression: A Population Dose-response Analysis.
    Chapel S; Chiu YY; Hsu J; Cucchiaro J; Loebel A
    Clin Ther; 2016 Jan; 38(1):4-15. PubMed ID: 26730454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lurasidone monotherapy in the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study.
    Loebel A; Cucchiaro J; Silva R; Kroger H; Hsu J; Sarma K; Sachs G
    Am J Psychiatry; 2014 Feb; 171(2):160-8. PubMed ID: 24170180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and Effectiveness of Long-Term Treatment with Lurasidone in Older Adults with Bipolar Depression: Post-Hoc Analysis of a 6-Month, Open-Label Study.
    Forester BP; Sajatovic M; Tsai J; Pikalov A; Cucchiaro J; Loebel A
    Am J Geriatr Psychiatry; 2018 Feb; 26(2):150-159. PubMed ID: 29146409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Lurasidone in Adults Aged 55 Years and Older With Bipolar Depression: Post Hoc Analysis of 2 Double-Blind, Placebo-Controlled Studies.
    Sajatovic M; Forester BP; Tsai J; Kroger H; Pikalov A; Cucchiaro J; Loebel A
    J Clin Psychiatry; 2016 Oct; 77(10):e1324-e1331. PubMed ID: 27529375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I).
    Young AH; McElroy SL; Bauer M; Philips N; Chang W; Olausson B; Paulsson B; Brecher M;
    J Clin Psychiatry; 2010 Feb; 71(2):150-62. PubMed ID: 20122369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical assessment of lurasidone benefit and risk in the treatment of bipolar I depression using number needed to treat, number needed to harm, and likelihood to be helped or harmed.
    Citrome L; Ketter TA; Cucchiaro J; Loebel A
    J Affect Disord; 2014 Feb; 155():20-7. PubMed ID: 24246116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of adjunctive oral ziprasidone for acute treatment of depression in patients with bipolar I disorder: a randomized, double-blind, placebo-controlled trial.
    Sachs GS; Ice KS; Chappell PB; Schwartz JH; Gurtovaya O; Vanderburg DG; Kasuba B
    J Clin Psychiatry; 2011 Oct; 72(10):1413-22. PubMed ID: 21672493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of adjunctive aripiprazole to either valproate or lithium in bipolar mania patients partially nonresponsive to valproate/lithium monotherapy: a placebo-controlled study.
    Vieta E; T'joen C; McQuade RD; Carson WH; Marcus RN; Sanchez R; Owen R; Nameche L
    Am J Psychiatry; 2008 Oct; 165(10):1316-25. PubMed ID: 18381903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bipolar I and II disorder residual symptoms: oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial.
    Juruena MF; Ottoni GL; Machado-Vieira R; Carneiro RM; Weingarthner N; Marquardt AR; Fleig SS; Broilo L; Busnello EA
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):94-9. PubMed ID: 19007842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy.
    Tohen M; Chengappa KN; Suppes T; Zarate CA; Calabrese JR; Bowden CL; Sachs GS; Kupfer DJ; Baker RW; Risser RC; Keeter EL; Feldman PD; Tollefson GD; Breier A
    Arch Gen Psychiatry; 2002 Jan; 59(1):62-9. PubMed ID: 11779284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjunctive lumateperone (ITI-007) in the treatment of bipolar depression: Results from a randomized placebo-controlled clinical trial.
    Suppes T; Durgam S; Kozauer SG; Chen R; Lakkis HD; Davis RE; Satlin A; Vanover KE; Mates S; McIntyre RS; Tohen M
    Bipolar Disord; 2023 Sep; 25(6):478-488. PubMed ID: 36779257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial.
    van der Loos ML; Mulder PG; Hartong EG; Blom MB; Vergouwen AC; de Keyzer HJ; Notten PJ; Luteijn ML; Timmermans MA; Vieta E; Nolen WA;
    J Clin Psychiatry; 2009 Feb; 70(2):223-31. PubMed ID: 19200421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LURASIDONE IN THE LONG-TERM TREATMENT OF PATIENTS WITH BIPOLAR DISORDER: A 24-WEEK OPEN-LABEL EXTENSION STUDY.
    Ketter TA; Sarma K; Silva R; Kroger H; Cucchiaro J; Loebel A
    Depress Anxiety; 2016 May; 33(5):424-34. PubMed ID: 26918425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.